jennifer gewandter

jennifer gewandter

University of Rochester

H-index: 33

North America-United States

About jennifer gewandter

jennifer gewandter, With an exceptional h-index of 33 and a recent h-index of 28 (since 2020), a distinguished researcher at University of Rochester, specializes in the field of Pain.

His recent articles reflect a diverse array of research interests and contributions to the field:

Mean of Daily Versus Single Week Recall-Based Pain Quality Assessments in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN) Trials: Implications for Assay Sensitivity

Personalized Trial Outcomes for Painful Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Strategy to Increase Assay Sensitivity

Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system

Expectations for improvement: a neglected but potentially important covariate or moderator for chronic pain clinical trials

Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION review and considerations

Treatment and assessment of neuropathic pain: Insights into clinical trial development

Optimizing and accelerating the development of precision pain treatments for chronic pain: IMMPACT review and recommendations

ID: 204233 Patient Centered Neuromodulation Trial: Shared Decision Making in the Era of Multiple Neuromodulation Paradigms

jennifer gewandter Information

University

Position

University of Rochester Medical Center

Citations(all)

3652

Citations(since 2020)

2686

Cited By

1964

hIndex(all)

33

hIndex(since 2020)

28

i10Index(all)

60

i10Index(since 2020)

53

Email

University Profile Page

University of Rochester

Google Scholar

View Google Scholar Profile

jennifer gewandter Skills & Research Interests

Pain

Top articles of jennifer gewandter

Title

Journal

Author(s)

Publication Date

Mean of Daily Versus Single Week Recall-Based Pain Quality Assessments in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN) Trials: Implications for Assay Sensitivity

The Journal of Pain

Madelaine S Rangel

Soroush Besharat

Michael B Sohn

Brian Burnette

Lori Francar

...

2024/4/1

Personalized Trial Outcomes for Painful Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Strategy to Increase Assay Sensitivity

The Journal of Pain

Karim Saab

Umang Gada

Eva Culakova

Carla Jorgensen

Dhaval Shah

...

2024/4/1

Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system

Ian R Kleckner

Thushini Manuweera

Po-Ju Lin

Kaitlin H Chung

Amber S Kleckner

...

2024/3/13

Expectations for improvement: a neglected but potentially important covariate or moderator for chronic pain clinical trials

The Journal of Pain

Dale J Langford

Raissa Lou

Soun Sheen

Dagmar Amtmann

Luana Colloca

...

2023/4/1

Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION review and considerations

Dale Jillian Langford

Dennis C Turk

Robert H Dworkin

Jennifer S Gewandter

2023/8/2

Treatment and assessment of neuropathic pain: Insights into clinical trial development

Journal of the Neurological Sciences

Jennifer Gewandter

2023/12/1

Optimizing and accelerating the development of precision pain treatments for chronic pain: IMMPACT review and recommendations

Robert R Edwards

Kristin L Schreiber

Robert H Dworkin

Dennis C Turk

Ralf Baron

...

2023/2/1

ID: 204233 Patient Centered Neuromodulation Trial: Shared Decision Making in the Era of Multiple Neuromodulation Paradigms

Neuromodulation

Soun Sheen

John Markman

Michael Sohn

Jennifer Gewandter

2023/6/1

Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Proof-of-Concept Randomized Clinical Trial

The journal of pain

Jennifer S Gewandter

Eva Culakova

Jenae N Davis

Umang Gada

Joseph J Guido

...

2023/11/21

Wireless transcutaneous electric nerve stimulation (TENS) for chemotherapy-induced peripheral neuropathy (CIPN): A proof-of-concept, placebo-controlled, randomized clinical …

Jennifer S Gewandter

Eva Culakova

Jenae N Davis

Umang Gada

Joseph John Guido

...

2023/6/1

Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes

Mahd Nishtar

Remington Mark

Dale J Langford

Michael P McDermott

John D Markman

...

2023/11/14

Cannabinoid Therapy: Attitudes and Experiences of People With Chronic Pain

The Clinical Journal of Pain

Jennifer S Gewandter

Robert R Edwards

Kevin P Hill

Ajay D Wasan

Julia E Hooker

...

2023/6/1

67. Feasibility of telehealth disability and functional assessments using wearables to improve spine patients care

The Spine Journal

Ram Haddas

Paul Rubery

Varun Puvanesarajah

Emmanuel Menga

Paul Geha

...

2023/9/1

Exploring Patients’ Understanding of Chemotherapy-Induced Peripheral Neuropathy

Journal of Cancer Education

Robert Knoerl

Donna L Berry

Jeffrey Meyerhardt

Kaitlen Reyes

Elahe Salehi

...

2023/6

Covariate Adjustment in Chronic Pain Trials: An Oft-Missed Opportunity

Dale J Langford

Sonia Sharma

Michael P McDermott

Avinash Beeram

Soroush Besherat

...

2023/9/1

Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement

Pain

David J Hohenschurz-Schmidt

Dan Cherkin

Andrew SC Rice

Robert H Dworkin

Dennis C Turk

...

2022/5/13

Partnering with patients in clinical trials of pain treatments: a narrative review

Katherine J Holzer

Christin Veasley

Robert D Kerns

Robert R Edwards

Jennifer S Gewandter

...

2022/10/1

Evaluation of the psychometric properties of patient-reported and clinician-reported outcome measures of chemotherapy-induced peripheral neuropathy: a COSMIN systematic review …

Philippe Bérubé-Mercier

Diane Tapp

Marie-Ève Cimon

Tiffany Li

Susanna B Park

...

2022/4/1

Patient-Reported Chronic Pain Intensity: More Than Meets the Eye

The Patient-Patient-Centered Outcomes Research

Dale J Langford

Jennifer S Gewandter

Dagmar Amtmann

Bryce B Reeve

Sharon Hertz

...

2022/7

USING PAIN TOLERABILITY THRESHOLDS TO CHARACTERIZE CLINICALLY MEANINGFUL TREATMENT OUTCOMES IN KNEE OSTEOARTHRITIS: POST HOC ANALYSIS OF A PHASE 2B TRIAL OF INTRA-ARTICULAR …

JD Markman

H Bennett

S Kennedy

JR Tambiah

CJ Swearingen

...

2022/4/1

See List of Professors in jennifer gewandter University(University of Rochester)